LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 62

Search options

  1. Article: Editorial: The expanding functional network of glutathione transferases.

    Piaggi, Simona / Diederich, Marc / Corti, Alessandro

    Frontiers in molecular biosciences

    2023  Volume 10, Page(s) 1146377

    Language English
    Publishing date 2023-01-31
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2814330-9
    ISSN 2296-889X
    ISSN 2296-889X
    DOI 10.3389/fmolb.2023.1146377
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Editorial

    Simona Piaggi / Marc Diederich / Alessandro Corti

    Frontiers in Molecular Biosciences, Vol

    The expanding functional network of glutathione transferases

    2023  Volume 10

    Keywords glutathione transferases ; inflammation ; pathogenesis ; polymorphisms ; steroid biochemistry ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Enhancement of ferroptosis by boric acid and its potential use as chemosensitizer in anticancer chemotherapy.

    Corti, Alessandro / Dominici, Silvia / Piaggi, Simona / Pompella, Alfonso

    BioFactors (Oxford, England)

    2022  Volume 49, Issue 2, Page(s) 405–414

    Abstract: Ferroptosis is a form of regulated cell death (RCD) characterized by intracellular iron ion accumulation and reactive oxygen species (ROS)-induced lipid peroxidation. Ferroptosis in cancer and ferroptosis-related anticancer drugs have recently gained ... ...

    Abstract Ferroptosis is a form of regulated cell death (RCD) characterized by intracellular iron ion accumulation and reactive oxygen species (ROS)-induced lipid peroxidation. Ferroptosis in cancer and ferroptosis-related anticancer drugs have recently gained interest in the field of cancer treatment. Boron is an essential trace element playing an important role in several biological processes. Recent studies have described contrasting effects of boric acid (BA) in cancer cells, ranging from protective/mitogenic to damaging/antiproliferative. Interestingly, boron has been shown to interfere with critical factors involved in ferroptosis-intracellular glutathione and lipid peroxidation in the first place. Thus, the present study was aimed to verify the ability of boron to modulate the ferroptotic process in HepG2 cells, a model of hepatocellular carcinoma. Our results indicate that-when used at high, pharmacological concentrations-BA can increase intracellular ROS, glutathione, and TBARS levels, and enhance ferroptosis induced by RSL3 and erastin. Also, high BA concentrations can directly induce ferroptosis, and such BA-induced ferroptosis can add to the cytotoxic effects of anticancer drugs sorafenib, doxorubicin and cisplatin. These observations suggest that BA could be exploited as a chemo-sensitizer agent in order to overcome cancer drug resistance in selected conditions. However, the possibility of reaching suitably high concentrations of BA in the tumor microenvironment will need to be further investigated.
    MeSH term(s) Humans ; Ferroptosis ; Cell Death ; Reactive Oxygen Species/metabolism ; Boron/pharmacology ; Boron/therapeutic use ; Lipid Peroxidation ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Liver Neoplasms/drug therapy ; Glutathione/metabolism ; Tumor Microenvironment
    Chemical Substances boric acid (R57ZHV85D4) ; Reactive Oxygen Species ; Boron (N9E3X5056Q) ; Antineoplastic Agents ; Glutathione (GAN16C9B8O)
    Language English
    Publishing date 2022-12-05
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 59230-4
    ISSN 1872-8081 ; 0951-6433
    ISSN (online) 1872-8081
    ISSN 0951-6433
    DOI 10.1002/biof.1919
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells-An Issue Still Open.

    Paties Montagner, Giulia / Dominici, Silvia / Piaggi, Simona / Pompella, Alfonso / Corti, Alessandro

    Antioxidants (Basel, Switzerland)

    2023  Volume 12, Issue 6

    Abstract: Boric acid (BA) is the dominant form of boron in plasma, playing a role in different physiological mechanisms such as cell replication. Toxic effects have been reported, both for high doses of boron and its deficiency. Contrasting results were, however, ... ...

    Abstract Boric acid (BA) is the dominant form of boron in plasma, playing a role in different physiological mechanisms such as cell replication. Toxic effects have been reported, both for high doses of boron and its deficiency. Contrasting results were, however, reported about the cytotoxicity of pharmacological BA concentrations on cancer cells. The aim of this review is to briefly summarize the main findings in the field ranging from the proposed mechanisms of BA uptake and actions to its effects on cancer cells.
    Language English
    Publishing date 2023-06-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox12061302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells—An Issue Still Open

    Paties Montagner, Giulia / Dominici, Silvia / Piaggi, Simona / Pompella, Alfonso / Corti, Alessandro

    Antioxidants. 2023 June 19, v. 12, no. 6

    2023  

    Abstract: Boric acid (BA) is the dominant form of boron in plasma, playing a role in different physiological mechanisms such as cell replication. Toxic effects have been reported, both for high doses of boron and its deficiency. Contrasting results were, however, ... ...

    Abstract Boric acid (BA) is the dominant form of boron in plasma, playing a role in different physiological mechanisms such as cell replication. Toxic effects have been reported, both for high doses of boron and its deficiency. Contrasting results were, however, reported about the cytotoxicity of pharmacological BA concentrations on cancer cells. The aim of this review is to briefly summarize the main findings in the field ranging from the proposed mechanisms of BA uptake and actions to its effects on cancer cells.
    Keywords boric acid ; boron ; cytotoxicity
    Language English
    Dates of publication 2023-0619
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article ; Online
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox12061302
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Anti-glutathione S-transferase omega 1-1 (GSTO1-1) antibodies are increased during acute and chronic inflammation in humans.

    Piaggi, Simona / Lorenzini, Evelina / Pratesi, Federico / Migliorini, Paola / Pompella, Alfonso / Bruschi, Fabrizio / Corti, Alessandro

    Clinical and experimental immunology

    2022  Volume 209, Issue 3, Page(s) 305–310

    Abstract: Glutathione S-transferase omega-1 (GSTO1-1) is a cytosolic enzyme involved in the modulation of critical inflammatory pathways as well as in cancer progression. Auto-antibodies against GSTO1-1 were detected in the serum of patients with esophageal ... ...

    Abstract Glutathione S-transferase omega-1 (GSTO1-1) is a cytosolic enzyme involved in the modulation of critical inflammatory pathways as well as in cancer progression. Auto-antibodies against GSTO1-1 were detected in the serum of patients with esophageal squamous cell carcinoma and were proposed as potential biomarkers in the early detection of the disease. Our findings show that anti-GSTO1-1 antibodies can be found in a variety of inflammatory diseases, including autoimmune rheumatoid arthritis, infectious SARS-CoV-2, and trichinellosis. Our findings strongly suggest that anti-GSTO1-1 antibodies may be a marker of tissue damage/inflammation rather than a specific tumor-associated biomarker.
    MeSH term(s) Biomarkers, Tumor ; COVID-19 ; Esophageal Neoplasms ; Esophageal Squamous Cell Carcinoma ; Glutathione Transferase ; Humans ; Inflammation ; SARS-CoV-2
    Chemical Substances Biomarkers, Tumor ; GSTO1 protein, human (EC 2.5.1.18) ; Glutathione Transferase (EC 2.5.1.18)
    Language English
    Publishing date 2022-06-19
    Publishing country England
    Document type Journal Article
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1093/cei/uxac060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Urea-based anticancer agents. Exploring 100-years of research with an eye to the future.

    Listro, Roberta / Rossino, Giacomo / Piaggi, Federica / Sonekan, Falilat Folasade / Rossi, Daniela / Linciano, Pasquale / Collina, Simona

    Frontiers in chemistry

    2022  Volume 10, Page(s) 995351

    Abstract: Suramin was the first urea-based drug to be approved in clinic, and in the following century a number of milestone drugs based on this scaffold were developed. Indeed, urea soon became a privileged scaffold in medicinal chemistry for its capability to ... ...

    Abstract Suramin was the first urea-based drug to be approved in clinic, and in the following century a number of milestone drugs based on this scaffold were developed. Indeed, urea soon became a privileged scaffold in medicinal chemistry for its capability to establish a peculiar network of drug-target interactions, for its physicochemical properties that are useful for tuning the druggability of the new chemical entities, and for its structural and synthetic versatility that opened the door to numerous drug design possibilities. In this review, we highlight the relevance of the urea moiety in the medicinal chemistry scenario of anticancer drugs with a special focus on the kinase inhibitors for which this scaffold represented and still represents a pivotal pharmacophoric feature. A general outlook on the approved drugs, recent patents, and current research in this field is herein provided, and the role of the urea moiety in the drug discovery process is discussed form a medicinal chemistry standpoint. We believe that the present review can benefit both academia and pharmaceutical companies' medicinal chemists to prompt research towards new urea derivatives as anticancer agents.
    Language English
    Publishing date 2022-09-15
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2711776-5
    ISSN 2296-2646
    ISSN 2296-2646
    DOI 10.3389/fchem.2022.995351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.

    Pierotti, Laura / Pardi, Elena / Dinoi, Elisa / Piaggi, Paolo / Borsari, Simona / Della Valentina, Simone / Sardella, Chiara / Michelucci, Angela / Caligo, Maria Adelaide / Bogazzi, Fausto / Marcocci, Claudio / Cetani, Filomena

    Frontiers in endocrinology

    2023  Volume 14, Page(s) 1191040

    Abstract: Background: Multiple Endocrine Neoplasia type 1 is a rare genetic syndrome mainly caused by mutations of : Methods: We collected phenotypic and genotypic data of 185 patients with F-: Results: The prevalence of angiofibromas was significantly ... ...

    Abstract Background: Multiple Endocrine Neoplasia type 1 is a rare genetic syndrome mainly caused by mutations of
    Methods: We collected phenotypic and genotypic data of 185 patients with F-
    Results: The prevalence of angiofibromas was significantly higher in F-
    Conclusions: We found a significantly higher prevalence of angiofibromas and lipomas in F-
    MeSH term(s) Humans ; Female ; Multiple Endocrine Neoplasia Type 1/genetics ; Angiofibroma/genetics ; Genetic Testing ; Mutation ; Lipoma/pathology
    Language English
    Publishing date 2023-07-07
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2023.1191040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Cognitive impairment, frailty and rehabilitation outcome in older cardiorespiratory patients. DEC_FRAinRIAB: Study protocol.

    Vigorè, Martina / Granata, Nicolò / Braga, Simona Sarzi / Piaggi, Giancarlo / Audifreddi, Silvia / Ferrari, Marina / La Rovere, Maria Teresa / Pierobon, Antonia

    PloS one

    2022  Volume 17, Issue 8, Page(s) e0272132

    Abstract: Background: Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two clinical conditions often associated with functional worsening, cognitive dysfunctions, treatment non-adherence, psychological distress and poor quality of ... ...

    Abstract Background: Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two clinical conditions often associated with functional worsening, cognitive dysfunctions, treatment non-adherence, psychological distress and poor quality of life (QoL). In addition, since patients suffering from these conditions are often older adults, the presence of frailty syndrome could worsen the clinical situation.
    Methods and design: This study protocol of a prospective multi-center clinical trial, will be conducted at two hospitals of the Istituti Clinici Scientifici Maugeri IRCCS group, from July 2020 until December 2022. CHF and COPD older patients (age ≥65) will undergo a multidisciplinary assessment at admission, discharge and at 6 months follow-up, from an inpatient rehabilitation program: disease-related clinical characteristics, functional variables, cognitive screening, treatment adherence, anxiety, depression, QoL and frailty. The estimated sample size will consist of 300 patients.
    Discussion: The expected results are related to the possibility of an improvement in the areas of intervention after the rehabilitative program and the maintenance of these improvements over time. The assessment of clinical and functional status, cognitive impairment, treatment adherence, psychosocial characteristics, and frailty could provide more specific and useful information about the main features to be considered in the evaluation and treatment of older patients suffering from CHF and COPD undergoing a rehabilitative pathway.
    Trial registration: The study has been registered on January 28, 2022 with the ClinicalTrials.gov NCT05230927 registration number (clinicaltrials.gov/ct2/show/NCT05230927).
    MeSH term(s) Aged ; Child, Preschool ; Chronic Disease ; Cognitive Dysfunction/complications ; Frail Elderly ; Frailty/complications ; Heart Failure/complications ; Humans ; Prospective Studies ; Pulmonary Disease, Chronic Obstructive ; Quality of Life ; Treatment Outcome
    Language English
    Publishing date 2022-08-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0272132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Frailty and rehabilitation outcome in older patients with cardiorespiratory disease: preliminary multidimensional data.

    Vigorè, Martina / Granata, Nicolo / Callegari, Giovanna / Vaninetti, Raffaella / Conti, Simona / Maestri, Roberto / Piaggi, Giancarlo / Cremonese, Gioele / Pierobon, Antonia

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2022  Volume 93, Issue 4

    Abstract: Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two clinical conditions often associated with cognitive dysfunctions, psychological distress, poor quality of life (QoL), and functional worsening. In addition, since ... ...

    Abstract Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are two clinical conditions often associated with cognitive dysfunctions, psychological distress, poor quality of life (QoL), and functional worsening. In addition, since patients suffering from these conditions are often older adults, frailty syndrome represents a further and important issue to be investigated. The present preliminary study aimed to perform a multidimensional assessment of CHF and/or COPD older patients (age ≥65) undergoing cardiac or pulmonary rehabilitation. The characteristics of the included patients (30 CHF and 30 COPD) resulted almost similar, except for the COPD patients' longer duration of illness and better performances in Addenbrooke's cognitive examination III subtests and short physical performance battery (SPPB). No significant differences were found in the frailty evaluation, but a consistent number of patients resulted to be frail (CHF=36.7% vs COPD=26.6%). After the rehabilitation program, a significant improvement was found in the whole sample concerning the executive functions (14.34±2.49 vs 15.62±2.22, p=0.001), quality of life (58.77±18.87 vs 65.82±18.45, p=0.003), depressive and anxious symptoms (6.27±4.21 vs 3.77±3.39, p=0.001 and 5.17±3.40 vs 3.38±3.21, p=0.001), frailty status [4.00 (3.00,5.00) vs 3.00 (3.00,5.00) p=0.035] and functional exercise abilities [SPPB, 7.40±3.10 vs 9.51±3.67, p=0.0002; timed up and go test, 14.62±4.90 vs 11.97±4.51, p<0.0001; 6-minute walking test, 353.85±127.62 vs 392.59±123.14, p=0.0002]. Preliminary results showed a substantial homogeneity of CHF and COPD older patients' cognitive, psychosocial, frailty, and functional characteristics. Nevertheless, the specific rehabilitation intervention appears promising in both clinical populations. This trial has been registered with the ClinicalTrials.gov, NCT05230927 registration number (clinicaltrials.gov/ct2/show/NCT05230927).
    MeSH term(s) Humans ; Aged ; Frailty/complications ; Quality of Life ; Frail Elderly ; Postural Balance ; Time and Motion Studies ; Pulmonary Disease, Chronic Obstructive ; Chronic Disease ; Treatment Outcome ; Heart Failure
    Language English
    Publishing date 2022-12-01
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2022.2447
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top